Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoi Karoulia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Reviews. Cancer|October 7, 2017
New perspectives for targeting RAF kinase in human cancerZoi Karoulia, Evripidis Gavathiotis, Poulikos I Poulikakos
Molecular and Cellular Biology|December 25, 2012
The phosphatase-transcription activator EYA1 is targeted by anaphase-promoting complex/Cdh1 for degradation at M-to-G1 transitionJianbo Sun, Zoi Karoulia, Elaine Y M Wong, et al.
Cell Reports|January 4, 2019
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent TumorsTamer A Ahmed, Christos Adamopoulos, Zoi Karoulia, et al.
Protein and Peptide Letters|September 15, 2012
Studies on the essential intramolecular interaction between the A1 and A2 domains of von Willebrand factorZoi Karoulia, Georgios Papadopoulos, Michail Nomikos, et al.
Cancer Cell|August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF SignalingZoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Cancer Discovery|February 11, 2021
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF SignalingChristos Adamopoulos, Tamer A Ahmed, Maxwell R Tucker, et al.
Nature Cancer|September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, et al.
The Journal of Experimental Medicine|December 22, 2017
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesionsBrandon Hogstad, Marie-Luise Berres, Rikhia Chakraborty, et al.
Nature Medicine|May 7, 2021
BRAF<sup>V600E</sup>-induced senescence drives Langerhans cell histiocytosis pathophysiologyCamille Bigenwald, Jessica Le Berichel, C Matthias Wilk, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Reviews. Cancer|October 7, 2017
New perspectives for targeting RAF kinase in human cancerZoi Karoulia, Evripidis Gavathiotis, Poulikos I Poulikakos
Molecular and Cellular Biology|December 25, 2012
The phosphatase-transcription activator EYA1 is targeted by anaphase-promoting complex/Cdh1 for degradation at M-to-G1 transitionJianbo Sun, Zoi Karoulia, Elaine Y M Wong, et al.
Cell Reports|January 4, 2019
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent TumorsTamer A Ahmed, Christos Adamopoulos, Zoi Karoulia, et al.
Protein and Peptide Letters|September 15, 2012
Studies on the essential intramolecular interaction between the A1 and A2 domains of von Willebrand factorZoi Karoulia, Georgios Papadopoulos, Michail Nomikos, et al.
Cancer Cell|August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF SignalingZoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Cancer Discovery|February 11, 2021
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF SignalingChristos Adamopoulos, Tamer A Ahmed, Maxwell R Tucker, et al.
Nature Cancer|September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, et al.
The Journal of Experimental Medicine|December 22, 2017
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesionsBrandon Hogstad, Marie-Luise Berres, Rikhia Chakraborty, et al.
Nature Medicine|May 7, 2021
BRAF<sup>V600E</sup>-induced senescence drives Langerhans cell histiocytosis pathophysiologyCamille Bigenwald, Jessica Le Berichel, C Matthias Wilk, et al.
Pageof 1